Targeting the epidermal growth factor receptor for cancer therapy

被引:392
作者
Mendelsohn, J [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1200/JCO.2002.07.121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1S / 13S
页数:13
相关论文
共 76 条
[1]   EFFICACY OF ANTIBODIES TO EPIDERMAL GROWTH-FACTOR RECEPTOR AGAINST KB CARCINOMA INVITRO AND IN NUDE-MICE [J].
ABOUDPIRAK, E ;
HURWITZ, E ;
PIRAK, ME ;
BELLOT, F ;
SCHLESSINGER, J ;
SELA, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (20) :1605-1611
[2]  
Albanell J, 2001, CANCER RES, V61, P6500
[3]   Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition [J].
Albanell, J ;
Rojo, F ;
Averbuch, S ;
Feyereislova, A ;
Mascaro, JM ;
Herbst, R ;
LoRusso, P ;
Rischin, D ;
Sauleda, S ;
Gee, J ;
Nicholson, RI ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :110-124
[4]  
[Anonymous], P AM SOC CLIN ONCOL
[5]  
BAKER CH, IN PRESS AM J PATHOL
[6]   SERUM-FREE CELL-CULTURE - A UNIFYING APPROACH [J].
BARNES, D ;
SATO, G .
CELL, 1980, 22 (03) :649-655
[7]   ANTITUMOR EFFECTS OF DOXORUBICIN IN COMBINATION WITH ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES [J].
BASELGA, J ;
NORTON, L ;
MASUI, H ;
PANDIELLA, A ;
COPLAN, K ;
MILLER, WH ;
MENDELSOHN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (16) :1327-1333
[8]  
Baselga J., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P380
[9]   Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx [J].
Bier, H ;
Hoffmann, T ;
Hauser, U ;
Wink, M ;
Öchler, M ;
Kovar, A ;
Müser, M ;
Knecht, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (06) :519-524
[10]  
Bos M, 1997, CLIN CANCER RES, V3, P2099